Blythe Medical

Aril® Acellular Allograft Amniotic Membrane

  • Sale
  • Regular price


  • Used to treat ocular surface diseases
  • Acellular amniotic membrane containing bioactive peptides for healing
  • Aril® processing eliminates potentially inflammation-causing cells of the chorion and epithelium , with greater than 95% reduction in DNA
  • Aril® processing uses no cryo-preservants, cross-linkers or antibiotics that may cause reaction in the eye
  • Placement is achieved without a ring
  • Available in 6 configurations
  • No up/down orientation
  • 5 year shelf life
  • Room temperature stable
  • Translucent to help monitor the healing process
  • Regulated by the FDA by 21 CFR Part 1271 and Section 361 of the PHS act
  • Billing code 65778 for placement without sutures.

[powr-media-gallery id=0a128fc0_1493758968]